Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may guide rheumatoid arthritis treatment decisions

NCT ID NCT03631225

Knowledge-focused Sponsor: Sequenom, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study looks at whether a blood test called Vectra can help doctors make better treatment choices for people with rheumatoid arthritis (RA). The test gives a score from 1 to 100 to show how active the disease is. About 1500 adults with RA will be split into two groups: one where doctors use the Vectra test to guide care, and another where they use standard methods. The goal is to see if using the test leads to better control of RA symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,500 people

The number who actually took part.

Started

Jun 2019

Finished

Jul 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients diagnosed with active rheumatoid arthritis at pre-determined clinical sites

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥ 18 years old at screening visit * Diagnosed with RA according to 1987 or 2010 criteria of the American College of Rheumatology * At the time of the pre-baseline visit, patient has a CDAI score of \>10 * Currently taking one or more non-biologic or biologic DMARD at screening and for at least the 3 months prior to screening * Visit at time of screening scheduled as part of routine care * Subject and/or physician willing to consider treatment change at screening * No expectation of imminent treatment change at screening or baseline visit Exclusion Criteria: * Currently taking an anti-IL-6R drug (tocilizumab, sarilumab) * Any contraindication, administrative barrier, or financial limitation (e.g. no insurance coverage) that makes it impossible for subject to receive at least one new biologic or JAKi therapy for RA * Active infection * History of malignancy within the past 5 years or any evidence of persistent malignancy, except fully excised basal cell or squamous cell carcinomas of the skin, or cervical carcinoma in situ that has been treated or excised in a curative procedure * Current enrollment in another clinical trial * Any condition or circumstance that makes it likely the patient will not be able to complete the trial

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rheumatoid arthritis (RA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rheumatoid arthritis (RA

Contacts and locations

Locations

  • AARDS Research, Inc.

    Aventura, Florida, 33180, United States

  • Accurate Clinical Research

    Lake Charles, Louisiana, 70605, United States

  • Accurate Clinical Research

    Baytown, Texas, 77521, United States

  • Accurate Clinical Research

    Houston, Texas, 77089, United States

  • Advanced Rheumatology & Arthritis Research Center, PC

    Wexford, Pennsylvania, 15090, United States

  • Altoona Center for Clinical Research

    Duncansville, Pennsylvania, 16635, United States

  • Artemisa Analytics

    Miami, Florida, 33133, United States

  • Arthritis Northwest, PLLC

    Spokane, Washington, 99204, United States

  • Arthritis and Diabetes Clinic, Inc.

    Monroe, Louisiana, 71203, United States

  • Arthritis and Osteoporosis Center of Northern Virginia

    Manassas, Virginia, 20109, United States

  • Aurora Rheumatology and Immunotherapy Center

    Franklin, Wisconsin, 53132, United States

  • Bio Solutions Clinical Research

    La Mesa, California, 91942, United States

  • Brigid Freyne, MD

    Murrieta, California, 92563, United States

  • CardioVoyage

    Sherman, Texas, 75090, United States

  • Carolina Health Specialists

    Myrtle Beach, South Carolina, 29572, United States

  • Center for Arthritis and Rheumatic Diseases, P.C.

    Chesapeake, Virginia, 23320, United States

  • Center for Arthritis and Rheumatic Diseases., P.C.

    Suffolk, Virginia, 23435, United States

  • Clin-Med Research & Development, LLC

    South Miami, Florida, 33141, United States

  • Clinvest Research, LLC.

    Springfield, Missouri, 65810, United States

  • Delaware Arthritis

    Lewes, Delaware, 19958, United States

  • East Penn Rheumatology Associates, P.C.

    Bethlehem, Pennsylvania, 18015, United States

  • J. Lee MD Medical Corp

    Orange, California, 92868, United States

  • North Mississippi Medical Center

    Tupelo, Mississippi, 38801, United States

  • PA Regional Center for Arthritis and Osteoporosis Research

    Wyomissing, Pennsylvania, 19610, United States

  • Paramount Medical Research & Consulting, LLC

    Middleburg Heights, Ohio, 44130, United States

  • Pioneer Research Solutions, Inc

    Cypress, Texas, 77429, United States

  • Rheumatology Associates of Central Florida, P.A.

    Orlando, Florida, 32806, United States

  • Rheumatology Associates of Long Island

    Smithtown, New York, 11787, United States

  • Robert W. Levin, MD, PA

    Clearwater, Florida, 33765, United States

  • Southern Ohio Rheumatology Inc.

    Wheelersburg, Ohio, 45694, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.